Clinical Trials Browser

Completed × Has results × Abatacept × Clear all

NCT01743131 2025-12-11

Abatacept as GVHD Prophylaxis Phase 2

Phase 2 Completed

186 enrolled 14 charts 1 FDA

Graft vs Host Disease, Neoplasms

NCT03680092 2025-10-02

Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantation

Phase 2 Completed

43 enrolled 10 charts

Other hematologic neoplasm

Graft vs Host Disease, Neoplasms, Hematologic Neoplasms

NCT01012492 2019-11-21

Pilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCT

Phase 2 Completed

11 enrolled 10 charts

Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, Leukemia, Myelodysplastic Syndromes, Neoplasms

NCT01351480 2017-03-13

Benefits of Injectable Abatacept Using Magnetic Resonance Imaging (MRI) in Rheumatoid Arthritis (RA) Patients

Phase 3 Completed

34 enrolled 8 charts

Arthritis, Arthritis, Rheumatoid

NCT01350804 2016-05-23

NURTURE 1

Phase 3 Completed

551 enrolled 19 charts

Arthritis, Rheumatoid

NCT00048581 2011-11-21

Phase III Study of BMS-188667 (CTLA4Ig) in Patients With Rheumatoid Arthritis Who Are Currently Failing Anti-TNF Therapy or Who Have Failed Anti-TNF Therapy in the Past.

Phase 3 Completed

738 enrolled 84 charts

Arthritis, Rheumatoid